Efficacy and safety of edaravone dexborneol in acute large vessel occlusion patients with successful recanalization after endovascular treatment

Background and purpose: Edaravone dexborneol (ED) is a novel cytoprotective drug for treating acute ischemic stroke (AIS) with synergistic antioxidant and anti-inflammatory effects. This study aimed to assess the efficacy and safety of ED in acute large vessel occlusion (LVO) patients with successfu...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Xiangliang Chen, Liyuan Wang, Yunyun Xiong, Zhenqiang Zhao, Kailai Huang, Zhenhui Duan, Kangmeng Wang, Chunhua Yun, Meipin Yang, Tianyi Xu, Wenhua Liu, Wei Li
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2025-12-01
Ráidu:	Journal of Stroke and Cerebrovascular Diseases
Fáttát:	Edaravone dexborneol Endovascular treatment Large vessel occlusion Acute ischemic stroke
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S1052305725002824
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!